Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives

G Sartori, L Belluomini, F Lombardo… - Expert Review of …, 2020 - Taylor & Francis
Introduction Afatinib is a second-generation epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitor, acting as an irreversible and multitarget blocker of ErbB family …
被引用次数：9 相关文章

Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives

G Sartori, L Belluomini, F Lombardo… - Expert review of …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Afatinib is a second-generation epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitor, acting as an irreversible and multitarget blocker of ErbB family …

Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives.

G Sartori, L Belluomini, F Lombardo… - Expert Review of …, 2020 - europepmc.org
Afatinib is a second-generation epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitor, acting as an irreversible and multitarget blocker of ErbB family members. Afatinib is …

Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives

G Sartori, F Lombardo, A Avancini, I Trestini… - EXPERT REVIEW OF …, 2020 - iris.univr.it
Introduction Afatinib is a second-generation epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitor, acting as an irreversible and multitarget blocker of ErbB family …